Notification

×

Iklan

Iklan

Tag Terpopuler

Bridging East and West: HKSTP Makes Landmark MEDICA Debut, Unlocking Hong Kong–Europe MedTech Pathways

Jumat, 20 November 2026 | 23:11 WIB Last Updated 2026-11-20T16:11:08Z
Klik
HKSTP concluded its first-ever delegation of 22 park companies and local university partners to MEDICA 2026 from 16 to 19 November in Düsseldorf, Germany.



DÜSSELDORF / HONG KONG – Hong Kong Science and Technology Parks Corporation (HKSTP) has wrapped up its inaugural delegation to MEDICA 2026 in Düsseldorf, Germany, cementing new cross-border alliances between Asia and Europe.

 Running from November 16 to 19, the showcase featured 22 park companies and local university partners—working alongside the Hong Kong Trade Development Council (HKTDC) and the Hong Kong MedTech Association—to spotlight breakthroughs in surgical robotics, diagnostics, ophthalmology, and rehabilitation.

The debut marks a strategic push to position Hong Kong as a premier two-way launchpad: helping Chinese innovators navigate European regulatory landscapes while offering European firms seamless entry into the Greater Bay Area and China’s rapidly expanding medical device market, projected to reach USD 82 billion by 2032.

"Turning breakthroughs into global healthcare solutions requires deep ecosystem collaboration," said Terry Wong, CEO of HKSTP. "Engaging key European partners is vital to building trusted cross-border pathways for regulatory readiness and market access, demonstrating how HKSTP connects world-class R&D with international markets."

Strategic Alliances and Commercial Deals

To formalize European market entry, HKSTP inked two landmark Memoranda of Understanding (MoUs) with German healthtech leaders Medical Valley EMN—focusing on clinical research and business matching—and Kalms Consulting, which will guide park ventures through European regulatory compliance and commercialization.

Individual park companies also secured concrete international deals on the show floor:

European Expansion: CRISPR-based diagnostics developer Orange Biotech signed an MoU with Hungarian medical device firm CorLab to explore EU distribution and potential local assembly.

Middle East Reach: Pushkang Biotechnology partnered with Egypt-based Keen Diagnostic Partners to deploy and commercialize its automated chemistry analyzers across Egyptian hospitals and clinics.

Global Product Premieres

Beyond deal-making, Hong Kong innovators unveiled CE-marked technologies tailored for global clinical and consumer markets:

AusMed Global held the European soft launch of KetoMetrics®, the world’s first portable, real-time breath ketone monitor delivering laboratory-grade accuracy for metabolic health and weight management.

Dymind debuted its upgraded DH-8000 hematology analysis workstation, engineered to streamline high-volume laboratory testing.

Deepening Ecosystem Ties

Throughout the four-day mission, HKSTP also co-hosted an executive roundtable with global law firm Clifford Chance and led delegation visits to industry giants including Siemens Healthineers and TUM Venture Labs. Supported by an ecosystem of over 400 life and health tech companies—several of which recently clinched top honors at BioJapan 2026 and the Washington Innovation & Entrepreneurship Competition—HKSTP continues to prove that Hong Kong’s biomedical R&D is both clinically validated and globally competitive.

Alternative Headlines:

HKSTP Debuts at MEDICA 2026, Inking Major German Alliances to Fast-Track Asia–Europe MedTech Trade

From Lab to Global Market: 22 Hong Kong Innovators Forge New European Partnerships at MEDICA 2026

×
Berita Terbaru Update